Jill M. Spoerke
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Chronic Lymphocytic Leukemia Research, Genetic factors in colorectal cancer
Most-Cited Works
- → A Missense Single-Nucleotide Polymorphism in a Gene Encoding a Protein Tyrosine Phosphatase (PTPN22) Is Associated with Rheumatoid Arthritis(2004)1,499 cited
- → Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase(2006)670 cited
- → EGO-1 is related to RNA-directed RNA polymerase and functions in germ-line development and RNA interference in C. elegans(2000)547 cited
- → First-in-Human Phase I Study of Pictilisib (GDC-0941), a Potent Pan–Class I Phosphatidylinositol-3-Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors(2014)356 cited
- → TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer(2011)312 cited
- → Molecular Biomarker Analyses Using Circulating Tumor Cells(2010)295 cited
- → Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant(2016)292 cited
- → GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway(2011)227 cited
- Erratum: EGO-1 is related to RNA-directed RNA polymerase and functions in germ-line development and RNA interference in C. elegans (Current Biology (2000) 10 (169-178))(2000)
- → ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors(2012)208 cited